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OBJECTIVES: Albumin and hemoglobin are viewed as markers of nutritional and 
inflammatory status. This study examined the associations of serum albumin and hemoglobin 
with physical function in community-living older adults.  
DESIGN:  Population-based cross-sectional and longitudinal study.  
SETTING: The Singapore Longitudinal Aging Studies (SLAS), a community-based study in 
urban Singapore. 
PARTICIPANTS: 2762 older adults aged 55 and above assessed at baseline, and 1829 at 
follow up 1-2 years later.  
MEASUREMENTS: Serum albumin and hemoglobin, Performance Oriented Mobility 
Assessment (POMA), knee extension strength at baseline, and Instrumental Activities of Daily 
Living (IADL) at baseline and follow up.  
RESULTS: In cross-sectional multivariate analyses that adjusted for haemoglobin and other 
confounders, albumin showed a significant linear association (p<0.001) with POMA balance 
score (b=0.06, SE=0.02) and knee extension strength (b=0.70, SE=0.10). Independently of 
albumin, hemoglobin also showed a significant linear association with POMA balance score 
(b=0.09, SE=0.04). In longitudinal analyses, albumin was significantly associated with IADL 
decline (IADL total score drop>=1 during follow-up), OR= 0.92 (0.87 - 0.97), p=<0.01.  
CONCLUSION: The findings suggest that low levels of albumin and hemoglobin are 
potentially useful risk markers of physical functional decline in older adults. Further research 
should investigate whether improvements in the levels of albumin and hemoglobin alter the 
level of functional disability and risk of functional decline. 




In ageing societies, the health services and social care needs of physically disabled 
older persons are a cause of great societal concern and burden. To devise and implement 
effective strategies for preventing or delaying the onset of physical disability, it is important to 
identify modifiable risk factors of physical functional limitations and disability. While 
research over decades have established a large number of modifiable risk factors for 
functional status decline in the elderly, nutritional factors have not been adequately 
investigated thus far (1).  
 
Albumin is a conventional marker of nutritional status. In community-living older 
persons, low albumin has been reported to be associated with impaired performance of 
activities of daily living (ADL) (2) and decline in muscle strength (3). However, other studies 
have also reported that albumin alone did not independently predict physical function decline 
measured by subjective questionnaire (4) or objective performance tests (5). The inconsistent 
results could possibly be attributed to the use of different instruments with varying sensitivity 
to assess physical functional performance.   
 
Another nutritional marker is hemoglobin. A growing body of evidence has linked 
"mild" anemia or low-normal hemoglobin in the elderly to adverse events (6). Population-
based studies have consistently reported an association between low hemoglobin and poor 
physical function (7-9) or greater decline in physical performance (10) among community-
living elderly persons. 
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So far, the relationship of albumin and hemoglobin with physical function has been 
studied in isolation, and not in tandem. Hence, their independent and relative effects on 
physical function are unclear. Albumin and hemoglobin are associated with distinct 
physiological processes and biological mechanisms in human body. Low albumin 
concentration is associated with sarcopenia and muscle strength decline in the elderly (11). As 
such, albumin has been proposed to be a marker of inflammatory response and increased 
vascular permeability that underline various chronic diseases (12). Low haemoglobin is well 
known to occur in individuals with chronic disease as a result of suppressed erythropoiesis by 
systemic inflammation (13).  
 
In the present study, we measured albumin and hemoglobin together, and physical 
function using both performance-based tests and self-reported questionnaire in a large sample 
of community dwelling elderly from the Singapore Longitudinal Ageing Studies cohort. We 
tested the hypothesis of linear associations between serum albumin and hemoglobin with 
measures of physical function, and investigated whether albumin or hemoglobin exerted a 




The Singapore Longitudinal Ageing Study (SLAS) is a prospective cohort 
observational study of ageing and health among community-dwelling elderly Singaporeans. 
During recruitment and baseline data collection between September 2003 and December 
2005, all older adult residents aged ≥55 years (N=2,804, 78% response rate) were identified 
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by door-to-door census in South East Singapore for participation in the study. Residents who 
were severely physically or mentally ill, and incapacitated to give informed consent or 
participate, were excluded. The study was approved by the National University of Singapore 
Institutional Review Board, and all participants gave signed informed consent. The details of 
the SLAS have been described in previous publications (14-16). 
 
For the current study, we performed cross-sectional analyses of 2,762 respondents who 
had complete baseline data for albumin, hemoglobin and performance-based assessment of 
gait, balance and strength. Longitudinal analyses for instrumental ADL ability was performed 
for 1,829 participants with baseline and follow up assessments at 1-2 years (median=1.5 
years) available for only instrumental ADL ability.   
 
Measurements 
Participants completed an extensive series of face-to-face interviews, assessments and 
tests which were performed by trained research nurses, in the preferred language (English or 
Chinese or Malay) or dialect.   
 
Self-reported physical function  
Self-reported physical functional status was assessed using items from the Lawton 
scale (17-19), which had been validated in previous studies. The subjects’ ability to perform 
instrumental activities of daily living were categorized as follows:  “unable to do at all” 
(score-0), “needed some assistance” (score-1), or “needed no help” (score-2). Higher summed 
IADL scores across different items represent higher function levels. IADL change score was 
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calculated by subtracting the follow up score from the baseline score and analyzed as a 
continuous variable. Subjects were defined as having suffered a decline in IADL function if 
their IADL score fell by 1 or more points during the follow up period, and analyzed as a 
dichotomous variable.  
 
Physical Performance tests 
Gait and balance were measured by the performance oriented mobility assessment 
(POMA) tool (20). Static sitting balance (rising from the sitting position without using hands) 
was assessed using graded scores by the need for assistance and the number of attempts; 
standing balance was assessed within the first five seconds after the subject’s sternum was 
gently pushed by the examiner, and when stance was stabilized. Staggering or excessive sway 
of the subject was examined wth the subject standing and his eyes closed. Steadiness and 
continuity of steps were observed with the subject turning in a complete 360 degree circle. 
Gait assessment was performed with the subject walking 6 meters and returning quickly to the 
starting point, noting the ability to initiate walking and any hesitancy, step height and length, 
the lack of symmetry or inability to clear the floor, step continuity, deviation in the path and 
walking stance. The POMA scores for balance and gait were tallied separately using standard 
scoring criteria, and a combined total score was determined.  
 
Testing of lower limb strength (knee extension muscle strength) was performed using 
a spring gauge attached to the subject’s leg using a webbing strap with a Velcro fastener. The 
force of the knee extensor was measured with the subject sitting on a tall chair with a strap 
around the leg 10 cm above the ankle joint, and the hip and knee joint angles positioned at 90 
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degrees. In 3 trials per muscle group, the subject attempts to pull against the strap assembly 
with maximal force for 2 to 3 seconds, and the greatest force for each muscle group was 
recorded. (21) 
Laboratory measurements 
Overnight fasting venous blood samples were analyzed for serum level of albumin 
(g/L) on an Advia 2400 auto-analyzer (Bayer HealthCare Diagnostics) using Bromcresol 
Green (BCG) dye binding method (CV ranging from 1%-3%). Measurements of hemoglobin 
level (g/dL) were performed on the same automated system.  
 
Other variables 
Other information collected included age, gender, education, housing type, cigarette 
smoking (current smokers, past-smokers, or non-smokers), alcohol consumption (at least 1 
alcoholic drink daily versus nil), and any hospitalization in the past 12 months. Body Mass 
Index (BMI) was calculated as kg/m
2
 with measured weight and height. 
 
Respondents were asked to report whether in the 12 months prior to the interview they 
were diagnosed and treated by a doctor for any one or more of a list of specific medical 
conditions, which included asthma, chronic obstructive pulmonary disease (COPD), coronary 
artery disease, heart failure, hypertension, diabetes mellitus, stroke, hip fracture, arthritis, 
cataract, and other conditions specified by them. The total number of co-morbidities was used 




Cognitive performance was assessed by the Mini-Mental State Examination (MMSE) 
(22), which has been externally validated for local use in another study population of 
Singaporean older adults. (23) Poor cognitive performance was defined by MMSE total score 
of 23 or less. 
 
The presence of depressive symptoms was assessed using the 15-item Geriatric 
Depression Scale (24, 25) which has been validated for use in local Chinese, Malay and Indian 
subjects (26, 27). The use of the GDS avoids the measurement artifact due to overlapping 
symptoms of the somatic illness and symptoms indicative of depression.  
 
Statistical analysis 
 Group comparisons of categorical and continuous variables were performed using 
chi-squared test or analysis of variance, as appropriate. In multiple regression and logistic 
regression analyses, POMA gait, POMA balance, knee extension strength, baseline IADL 
score , IADL change score (continuous variable) and IADL decline (dichotomous variable) 
were analyzed as dependent variables. Regression coefficient (b) or odds ratio (OR) of 
association for albumin and hemoglobin (continuous variables) were estimated in base models 
(Model 1: unadjusted), and adjusted in hierarchical models that controlled for age, gender, 
education, housing type, number of co-morbidities, hospitalization in past year, GDS score, 
MMSE score, body mass index, creatinine level, history of arthritis and hip fracture (Model 
2); and finally with hemoglobin and albumin together (Model 3). Baseline IADL score was 
significantly associated with serum albumin and hemoglobin and predicted future decline of 
physical function, however in some plausible situations, adjusting for baseline health status 
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may inflate regression coefficient estimates for the effect (28). In longitudinal analyses, 
therefore, the multivariate models included models (Model 3) with and without (Model 2) 
baseline IADL scores as a baseline covariate. In further analyses, subjects with IADL 
disability (needing any help in IADL) at baseline were excluded (Model 5), to determine the 
effect of albumin and hemoglobin in well functioning individuals in predicting incident cases 
of IADL functional decline. A 2-sided p value of less than 0.05 was considered as statistically 
significant. All analyses were carried out with SPSS statistical software version 18.0 (SPSS, 




Table 1 displays characteristics of the study sample. The mean age of the study 
participants was 66 (SD=7.7), and 1430 (51.8%) had less than 6 years of schooling. Low 
albumin (<38 g/L) was present in 199 (7.2%) of the participants and low hemoglobin (<12g/dl 
in females and <13g/dl in males) was found in 397 (14.4%).   
 
POMA scores, knee extension and IADL scores were lower in anemic (versus non-
anaemic) and hypoalbuminemic (versus normoalbuminaemic) respondents (p < 0.05) (Table-
1). Anemic and hypoalbuminemic respondents were also noted to have lower MMSE score, 
GDS score, increased age, lower socio-economic status, more co-morbidities and 





Cross-sectional analyses (Table 2) showed that in the unadjusted base model (Model 
1), albumin was significantly associated with POMA gait, POMA balance scores, knee 
extension strength and IADL scores (p<0.01). Controlling for gender, age, education, housing 
type, number of co-morbidities, hospitalization, GDS score, MMSE score, body mass index 
creatinine level and history of arthritis and hip fracture (Model 2), albumin  was positively 
associated with POMA balance score and knee extension strength (p<0.01). With further 
adjustments for hemoglobin (Model 3), albumin remained significantly associated with 
POMA balance score (b=0.06, p<0.01) and knee extension strength (b=0.70, p<0.01). 
 
Hemoglobin was significantly associated with all objective physical function measures 
in the unadjusted model (p<0.01), but only the association with POMA balance score (b=0.09, 
p=0.04) remained statistical significant when all potential confounder variables and albumin 
were adjusted for in model 3. (Table 2) 
 
 From follow up, 10% of participants (n=182) showed IADL decline.  Longitudinal 
analyses (Table 3) showed that albumin was significantly associated with IADL decline (OR= 
0.87, 95% CI = 0.83-0.92) in the unadjusted base model (Model 1). Controlling for gender, 
age, education, housing type, number of co-morbidities, hospitalization, GDS score, MMSE 
score, body mass index, creatinine level and history of arthritis and hip fracture (Model 2), 
albumin  was significantly associated with IADL decline (OR= 0.92, 95% CI = 0.87-0.97). 
Further adjustments for baseline IADL scores (Model 3) and hemoglobin (Model 4) showed 
that albumin remained significantly associated with IADL decline (OR= 0.92, 95% CI = 0.87-
0.97). In further analyses that excluded subjects with IADL disability at baseline, we obtained 
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similar results (Model 5. OR= 0.91, 95% CI = 0.85-0.98). Similar results were obtained when 
IADL change score (continuous variable) was used as the dependent variable (regression 
coefficient was -0.02 (SE= 0.008, P=0.01 in the final model).  
  
Hemoglobin was not found to be significantly associated with IADL change score and 
IADL decline. Interaction between albumin and hemoglobin was explored, and no statistically 
significant interactions were found.  
 
DISCUSSION 
In this community-based sample of older persons in Singapore, we found that serum 
albumin was linearly associated with POMA balance score, knee extension strength, IADL 
change score and IADL decline at follow-up. Serum hemoglobin was significantly associated 
with POMA balance score only.  
 
Our findings are in line with previous studies that reported an association between 
albumin or hemoglobin with physical function in the elderly (2, 3, 7-10). The associations we 
observed remained statistically significant after adjusting for co-morbidities, cognitive 
function, depressive symptoms and other variables, suggesting that the relationships were not 
due to other health variables.  The linear trend associations of albumin and hemoglobin with 
physical function suggest effects across the whole range of values of these continuous 
variables that are in line with previous findings (3, 7). Both low and low normal values of 
albumin or hemoglobin were associated with decreased physical function in healthy 
community dwelling older adults, and the use of conventional clinical cutoff values for 
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albumin or hemoglobin may therefore not be applicable in healthy community dwelling older 
adults who are at risk of functional decline. Among well-functioning individuals, low and low 
normal values of albumin in particular were found to predict future risks of functional decline, 
suggesting that they are potentially useful risk markers of physical functional decline in older 
adults. 
 
Furthermore, our results in regression models that controlled simultaneously for both 
albumin and hemoglobin suggest that albumin had clearly more pronounced effect on physical 
function as compared with hemoglobin. This was clearly most evident in longitudinal analyses 
in which albumin but not hemoglobin, was found to be significantly associated with IADL 
decline.  
 
This is the first study that has examined the independent associations of albumin and 
hemoglobin with physical function in community-living older adults.  Previous studies (7-10) 
have not adjusted for albumin when they examined the association between hemoglobin and 
physical function. In these studies, therefore, the actual effect size of the association between 
hemoglobin and physical function could be smaller than reported.  
 
Given the reasonably good baseline BMI status and albumin and hemoglobin values in 
this cohort of well functioning community dwelling older adults, lower albumin values are 
less likely to be attributable to malnutrition. The association between serum albumin and 
physical function may be explained by two inter-related biological mechanisms. Firstly, 
albumin concentration is associated with age-associated skeletal muscle loss (sarcopenia) in 
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older persons (11). Increased muscle breakdown and muscle depletion lead to decline in 
muscle strength, which could mediate the observed albumin-physical function associations. 
Secondly, albumin is a negative acute phase protein that decreases with
 
systemic inflammation 
and is conventionally viewed as a marker of chronic inflammation. Since pro-inflammatory 
cytokines may cause muscle atrophy and has been associated with physical disability (29) or 
function decline (4), the observed association between albumin and physical function is also 
partly explained by chronic inflammation. 
 
Since pro-inflammatory cytokines affect hematopoiesis, anemia in old age due to 
chronic inflammation may arguably explain the association of hemoglobin with physical 
limitations (6). Our analysis adjusting for albumin (as a surrogate marker of inflammation) 
suggest that the observed association between hemoglobin and physical imitations was 
mediated by other non-inflammatory mechanisms. More likely, the relationship between 
hemoglobin and physical function may be secondary to the effects of fatigue, weakness, poor 
muscle oxygenation, and low level of physical activity that is associated with anemia (9, 30, 
31).  
 
The strengths of this study included a large population-based sample and the use of 
both objective and subjective measures to assess physical function limitations and ADL 
disability. The multivariate analysis controlled for a wide range of potential confounders 
hence the results appear robust and reliable. A limitation of the study was that physical 
performance tests were not repeated at follow up, hence we were only able to demonstrate 
longitudinal relationship for albumin with IADL decline. Also, pro-inflammatory cytokines 
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(such as IL-6, C-reactive protein, TNF-a, and others) were not measured, hence we were not 
able to examine the specific mediating roles of those cytokines in physical functional status 
and decline. Also we did not include upper extremity measures of physical function or lean 
body mass and other anthropometric measures of nutrition and sarcopenia.  
 
CONCLUSION 
            The significant associations of serum albumin and hemoglobin with physical function 
in community living older adults have practical implications for the prevention of physical 
disability in old age. The findings suggest that low levels of albumin and hemoglobin are 
potentially useful risk markers of physical functional decline in older adults. Further research 
should investigate whether improvements in the levels of albumin and hemoglobin alter the 
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Table 1 Description of the study participants (n= 2762) 
Variables 
  Low Albumin (<38 g/L)    Anemia 
a
 
Yes (N=199)  No (N=2563)  P
b
  Yes (397)  No (2365)  P
b
 
Hemoglobin (g/dL),  12.6±1.6 (6.5-16.9)  13.6±1.3 (8.5-18.6)  <0.01  11.5±0.9 (6.5-12.9)  13.8±1.1 (12-18.6)  <0.01 
Anemia, N (%) 74(37.2)  323(12.6)  <0.01  -  -  - 
Albumin (g/L) 35.9±1.5 (30-37)  42.7±2.8 (38-54)  <0.01  40.7±3.6 (30-52)  42.4±3.1 (31-54)  <0.01 
Low Albumin (<38 g/L), N (%) -  -  -  74(18.6)  125 (5.3)  <0.01 
Age 70.7±9.3 (55.1-95.7)  65.6±7.4 (55-97.6)  <0.01  69.6±9.1 (55.1-97.1)  65.4±7.2 (55-97.6)  <0.01 
Gender (female), N (%) 125(62.8)  1619 (63.2)  0.9  257(64.7)  1487 (62.9)  0.47 
Education (primary and below), N (%) 130 (65.3)  1300 (50.7)  <0.01  246 (62)  1184(50.1)  <0.01 
Housing type (≤3 rooms), N (%) 117 (58.8)  738 (28.8)  <0.01  163 (41.1)  692 (29.3)  <0.01 
Number of co morbidities 2.4±1.7 (0-6)  2.3±1.5 (0-9)  0.36  2.6±1.6 (0-9)  2.3±1.4 (0-9)  <0.01 
Hospitalized in past year, N (%) 14 (7.0)  96 (3.7)  0.02  28 (7.1)  82 (3.5)  <0.01 
Current and Ex smoker, N (%) 14 (7.0)  449(17.5)  <0.01  65 (16.4)  398(16.9)  0.8 
Alcohol Drinker, N (%) 24 (12.1)  271(10.6)  0.5  44(11.1)  251(10.6)  0.76 
BMI (kg/m2) 23.6±4.9 (13.1-44.9)  23.8±3.7 (12.5-43.9)  0.5  22.5±3.8 (13.6-44.7)  23.9±3.7 (12.5-44.9)  <0.01 
Creatinine(umol/L) 80.9±23.8 (38-166)  80.6±25.9 (34-468)  0.8  86.4±39.7 (38-468)  79.6±22.4 (34-388)  <0.01 
History of arthritis, hip fracture, N (%) 32 (16.1)  447 (17.4)  0.7  68 (17.1)  411 (17.4)  0.9 
MMSE total score 24.7±5.7 (4-30)  27.1±3.3 (3-30)  <0.01  25.6±4.6 (5-30)  27.1±3.4 (3-30)  <0.01 
MMSE <24, N (%) 52 (26.5)  295 (11.5)  <0.01  92 (23.4)  255(10.8)  <0.01 
GDS total score 2.6±3.5 (0-15)  1.8±2.7 (0-15)  <0.01  2.4±3 (0-15)  1.8±2.7 (0-15)  <0.01 
GDS>=5, N (%) 40 (20.2)  321 (12.6)  <0.01  73 (18.5)  288(12.2)  <0.01 
POMA total score at baseline 30.4±5.7 (1-35)  32.6±3.2 (5-35)  <0.01  31.1±4.7 (5-35)  32.7±3.2 (1-35)  <0.01 
POMA Gait score 8.7±1.2 (0-9)  8.9±0.5 (0-9)  <0.01  8.8±0.9 (0-9)  8.9±0.5 (0-9)  <0.01 
POMA Balance score 21.5±5.2 (0-26)  23.7±2.9 (4-26)  <0.01  22.3±4.2 (1-26)  23.7±2.9 (0-26)  <0.01 
Knee extension (kg) 21.9±8.3 (8-37)  27.4±12.1 (6-212)  0.01  23±8.5 (8-46)  27.7±12.3 (6-212)  <0.01 
IADL score 12.3±3.6 (0-14)  13.4±1.8 (0-14)  <0.01  12.97±2.8 (0-14)  13.4±1.8 (0-14)  <0.01 
            
Figures shown are  mean±SD (range) or N (%) 
a 
 WHO criteria: <12g/dl for women and <13 g/dl for men 
b 
Independent sample t test for continuous variables, chi-square test for categorical variables 
BMI= Body Mass Index, MMSE= Mini-mental state examination, GDS= Geriatric Depression Score, POMA=Performance oriented mobility 
assessment, IADL= Instrumental Activity of Daily Living, SD= Standard deviation 
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Table 2. Cross-sectional analysis: associations of albumin and hemoglobin with physical performance measures 
  POMA gait   POMA balance   Knee Extension Strength 
  b ± SE  Beta p  b ± SE beta p  b ± SE beta P 
Albumin                       
Model 1 0.02 ± 0.003  0.09 <0.01  0.18 ± 0.02 0.19 <0.01  1.1 ± 0.2 0.3 <0.01 
Model 2 0.003 ± 0.003 0.02 0.3  0.07 ± 0.02 0.07 <0.01  0.8 ± 0.1     0.2 <0.01 
Model 3 0.003 ± 0.003 0.02 0.4  0.06 ± 0.02 0.06 <0.01  0.7 ± 0.1     0.2 <0.01 
Hemoglobin            
Model 1 0.05±0.008 0.1 <0.01  0.4±0.04 0.16 <0.01  3±0.3 0.3 <0.01 
Model 2 0.01±0.008 0.03 0.2  0.13±0.04 0.06 <0.01  1.03±0.3 0.12 <0.01 
Model 3 0.009 ± 0.009 0.02 0.3   0.09±0.04 0.04 0.03   0.6±0.3 0.08 0.06 
 
MMSE= Mini-mental state examination, GDS= Geriatric Depression Score, POMA=Performance oriented mobility assessment, 
IADL= Instrumental Activity of Daily Living, b= unstandardized coefficients, SE= standard error, beta= standardized coefficients 
Model 1: Unadjusted 
Model 2: Adjusted for age, gender, education, housing type, number of co morbidities, hospitalization in past year; GDS score, 
MMSE score, body mass index(BMI), creatinine level and history of arthritis and hip fracture; 




Table 3. Longitudinal analysis: association of baseline albumin and hemoglobin level with IADL decline (N=1829) 
    IADL change   IADL decline* 
    b± SE beta p   OR 95% CI P 
Albumin         
Model 1  -0.03 ± 0.01 -0.06 <0.01  0.87 0.83 - 0.92 <0.01 
Model 2  -0.02 ± 0.007 -0.05 <0.01  0.92 0.87 – 0.97 <0.01 
Model 3  -0.03 ± 0.01 -0.06 <0.01  0.92 0.87 – 0.97 <0.01 
Model 4  -0.02 ± 0.007 -0.05 0.01  0.92 0.87 – 0.97 <0.01 
Model 5  -0.02 ± 0.008 -0.07 0.01  0.91 0.85 – 0.98 0.01 
         
Hemoglobin         
Model 1  -0.02 ± 0.02 -0.02 0.5  0.94 0.84 – 1.11 0.3 
Model 2  -0.02 ± 0.03 -0.02 0.6  0.95 0.83 – 1.11 0.5 
Model 3  -0.02 ± 0.03 -0.02 0.4  0.95 0.83 – 1.11 0.5 
Model 4  -0.001 ± 0.03 -0.001 0.9  0.99 0.86 – 1.15 0.9 
Model 5   -0.02 ± 0.02 -0.03 0.4   0.94 0.79 – 1.13 0.5 
 
* Defined as ≥1 point decline on IADL score during follow-up period 
MMSE= Mini-mental state examination, GDS= Geriatric Depression Score, POMA=Performance oriented mobility assessment, 
IADL= Instrumental Activity of Daily Living, b= unstandardized coefficients, SE= standard error, beta= standardized 
coefficients, CI= confidence interval 
Model 1: Unadjusted 
Model 2: Adjusted for age, gender, education, housing type, number of co morbidities, hospitalization in past year; GDS score, 
MMSE score, body mass index(BMI) , creatinine level and history of arthritis and hip fracture 
Model 3: Adjusted for age, gender, education, housing type, number of co morbidities, hospitalization in past year; GDS score, 
MMSE score, body mass index(BMI) , creatinine level and history of arthritis and hip fracture, plus IADL score at baseline  
Model 4: Adjusted for variables in Model 2 plus haemoglobin (or albumin)  
Model 5: Excluded subjects with IADL disability at baseline (N=1435), adjusted for variables in Model 4. (Baseline IADL score 
not included). 
